Genetic loss of STK11 remodels the tumor cytokine milieu, inducing upregulated expression of proinflammatory mediators—including CXCL7, G-CSF, IL-1β, and IL-6—which promotes neutrophil recruitment and suppresses T-effector cell function [93]. The gene discussed is IL6; the disease is neoplasm.